- In this note, we are introducing Universal Ibogaine Inc. (“UI”), a privately held company building an addiction treatment business. UI plans to file a Clinical Trial Application with Health Canada by mid 2021, as well as open ibogaine based psychotherapy centres in jurisdictions where ibogaine use is legal.
- To read more about Universal Ibogaine Inc. click below on downloads
Visit Universal Ibogaine Inc. page for more research, discussion boards and to like, and share.
Are you enjoying the highlights?
Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.
Already a member? Sign In
Investors are also interested in:
Delta 9 Cannabis Inc.(TSX: DN / OTCQX: VRNDF) – Launching Decontamination and COVID-19 Vaccine Storage Tech
Kaya Holdings Inc. (OTCQB: KAYS) – Vertically Integrated U.S. Cannabis Company to Tap into Growth Opportunities in Europe – Introductory Note